Pharmatalks
International Channel🎉 @Pharmatalks Chat group ✔️ @Pharmatalks_group Ads تبلیغات🔝 @Pharmatalkads Pharmacopoeia 📚 @USP_2024
Больше📈 Аналитический обзор Telegram-канала Pharmatalks
Канал Pharmatalks (@pharmatalks) языкового сегмента Английский является активным участником. Сейчас сообщество объединяет 17 991 подписчиков, занимая 11 176 место в категории Образование и 2 160 место в регионе США.
📊 Показатели аудитории и динамика
С момента создания невідомо проект демонстрирует стремительный рост, собрав аудиторию из 17 991 подписчиков.
Согласно последним данным от 24 июня, 2026, канал показывает стабильную активность. За последние 30 дней изменение числа участников составило -66, а за последние 24 часа — -8, при этом общий охват остаётся высоким.
- Статус верификации: Не верифицирован
- Уровень вовлечённости (ER): Средний показатель вовлечённости аудитории составляет 16.03%. В первые 24 часа после публикации контент обычно набирает 3.62% реакций от общего числа подписчиков.
- Охват публикаций: В среднем каждый пост получает 2 885 просмотров. В течение первых суток публикация набирает 651 просмотров.
- Реакции и взаимодействия: Аудитория активно поддерживает контент: среднее количество реакций на один пост — 5.
- Тематические интересы: Контент сосредоточен на ключевых темах, таких как validation, pharma, pharmatalk, qualification, iso.
📝 Описание и контентная политика
Автор описывает ресурс как площадку для выражения субъективного мнения:
“International Channel🎉 @Pharmatalks
Chat group ✔️ @Pharmatalks_group
Ads تبلیغات🔝 @Pharmatalkads
Pharmacopoeia 📚 @USP_2024”
Благодаря высокой частоте обновлений (последние данные получены 25 июня, 2026) канал поддерживает актуальность и высокий уровень охвата публикаций. Аналитика показывает, что аудитория активно взаимодействует с контентом, что делает его важной точкой влияния в категории Образование.
Загрузка данных...
| Дата | Привлечение подписчиков | Упоминания | Каналы | |
| 25 июня | +4 | |||
| 24 июня | +1 | |||
| 23 июня | +1 | |||
| 22 июня | +1 | |||
| 21 июня | 0 | |||
| 20 июня | +2 | |||
| 19 июня | +2 | |||
| 18 июня | +1 | |||
| 17 июня | 0 | |||
| 16 июня | 0 | |||
| 15 июня | 0 | |||
| 14 июня | 0 | |||
| 13 июня | 0 | |||
| 12 июня | 0 | |||
| 11 июня | 0 | |||
| 10 июня | 0 | |||
| 09 июня | 0 | |||
| 08 июня | 0 | |||
| 07 июня | +1 | |||
| 06 июня | 0 | |||
| 05 июня | +8 | |||
| 04 июня | +5 | |||
| 03 июня | +27 | |||
| 02 июня | +1 | |||
| 01 июня | 0 |
| 2 | 4 Bad Practice in Grad B Cleanrooms | 902 |
| 3 | 🚨 Top 5 GMP Violations Every Pharma Professional Must Know!
Watch Full Nice 😊 animated video and share your experience in video comments
https://youtu.be/f4efec___3E | 1 104 |
| 4 | 🚨 Top 5 GMP Violations Every Pharma Professional Must Know!
Watch Full Nice 😊 animated video and share your experience in video comments
https://youtu.be/f4efec___3E | 1 |
| 5 | Pharmatalks 504 Pharmaceutical Terms | 1 502 |
| 6 | ⏱️ Steps for Handling OOS Results
Watch Now Full Guide Here https://youtu.be/kE6fza6mLgc
⛨ Phase 1: Laboratory Investigation
✔ Immediate actions
✔ Analyst’s self-check
✔ Instrument review
✔ Sample preparation verification
✔ Chromatograms review (integration errors, system suitability)
⛨ Phase 1 Outcome
Invalid result → assign root cause, re-test allowed.
No assignable cause → move to Full-Scale Investigation.
⛨ Phase 2: Full-Scale Investigation (QA + Production)
✔ Review of manufacturing batch records
✔ Review of deviations, environment, equipment
✔ Evaluation of analyst training
✔ Hypothesis testing (additional testing if justified)
✔ Impact assessment on other batches | 1 045 |
| 7 | Нет текста... | 1 453 |
| 8 | Area Qualification in Pharma ensures that a facility or controlled area is suitable for its intended pharmaceutical operations.
http://youtube.com/post/UgkxdX7uDRE6LUNeN8WCenWHTGP1m65hj5pV?si=fSarmXGfnlSYLDbB
Key points include:
✅ Temperature control
✅ Humidity monitoring
✅ Differential pressure checks
✅ Air changes verification
✅ Layout and material flow assessment
✅ Compliance and safety review
Proper area qualification helps reduce contamination risk, support GMP compliance, and improve operational reliability.
Subscribe to Pharmatalks YouTube channel for more pharma knowledge, GMP updates, and cleanroom insights. | 1 636 |
| 9 | SOP on VMP.pdf | 1 919 |
| 10 | QA vs QM in Project Management: What’s the real difference?
QA helps teams follow the right process.
QM makes sure the whole project delivers quality consistently.
In real projects, both matter. QA prevents mistakes. QM connects quality goals, team performance, risk control, KPIs, and continuous improvement.
Enroll NOW in Pharmaceutical Project Manager Career Path HERE
✅ Pharmaceutical Project Manager Career Path
https://pharmuni.com/career-path/3/pharmaceutical-project-manager | 2 495 |
| 11 | ⚠️ Risk Management in the Pharmaceutical Industry
In pharma, risk management helps teams protect patients, ensure quality, and maintain compliance.
It also supports better decisions before small issues become major problems.
Key risk areas include:
✅ Quality risk
✅ Operational risk
✅ Compliance risk
✅ Supply chain risk
✅ Safety risk
✅ Data integrity risk
✅ Equipment and process risk
Common risk management tools include:
🔹 FMEA
🔹 HAZOP
🔹 Root Cause Analysis
🔹 Risk Matrix
🔹 Pareto Analysis
🔹 Checklists and SOPs
Strong risk management helps pharma teams:
✅ Identify risks early
✅ Prioritize high-impact issues
✅ Reduce deviations and errors
✅ Improve CAPA effectiveness
✅ Strengthen GMP compliance
✅ Support patient safety
Risk management is not just a document.
It is a proactive mindset for safer products and stronger quality systems.
Want to build stronger GMP risk management skills?
👉 Explore Pharmuni’s GMP Risk Management Principles course:
https://pharmuni.com/courses/18/gmp-risk-management-principles | 3 221 |
| 12 | Where Are the Best Biotech and Pharmaceutical Jobs in the USA? 🇺🇸💊
📍 Top States for Biotech and Pharma Careers:
✅ California – Strong biotech hubs, innovation, and research opportunities.
✅ Massachusetts – Known for biotech startups, R&D, and scientific innovation.
✅ New Jersey – Home to major pharmaceutical headquarters and regulatory roles.
✅ North Carolina – Growing opportunities in bioprocessing and manufacturing.
✅ Pennsylvania – Expanding biotech, production, and quality career options.
✅ Texas – Rising demand in clinical research and life sciences manufacturing.
Whether you are starting your career or seeking your next position, focus on the right location, build relevant skills, and explore opportunities consistently.
🚀 Ready to take the next step in your pharmaceutical career?
Explore pharma job opportunities on Pharmuni:
https://l1nq.com/eevf8pq | 3 255 |
| 13 | 🔐 Key Requirements of 21 CFR Part 11 Training
In regulated pharma environments, electronic records and electronic signatures must be controlled, traceable, and reliable.
Teams should understand:
✅ When 21 CFR Part 11 applies
✅ Why computerized systems need validation
✅ How audit trails support traceability
✅ Why access control protects data integrity
✅ How electronic signatures must be managed
✅ Why SOPs and training are essential
✅ How record integrity supports inspection readiness
21 CFR Part 11 is not only an IT topic.
It connects quality, compliance, validation, documentation, and patient safety.
Want to build stronger knowledge in computerized system compliance?
👉 Explore Pharmuni’s Introduction to Computer Systems Validation (CSV) course:
https://shorturl.at/EyAuD | 2 821 |
| 14 | 🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard
.
Key points include:
✅ A structured clinical protocol guideline
✅ A standardized protocol template
✅ A technical specification for digital exchange
✅ Better consistency across trial submissions
✅ Improved clarity for sponsors and regulators
✅ Less ambiguity in protocol content
✅ Stronger support for global clinical trial efficiency
📌 Read the full news here: https://sl1nk.com/kd7xmys | 3 162 |
| 15 | 🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard
.
Key points include:
✅ A structured clinical protocol guideline
✅ A standardized protocol template
✅ A technical specification for digital exchange
✅ Better consistency across trial submissions
✅ Improved clarity for sponsors and regulators
✅ Less ambiguity in protocol content
✅ Stronger support for global clinical trial efficiency
📌 Read the full news here: https://sl1nk.com/kd7xmys | 1 |
| 16 | ⚙️ Common Pitfalls in IQ, OQ, and PQ
.
✅ Incomplete installation records
✅ Missing utility or component checks
✅ Poorly defined test parameters
✅ Untrained personnel running tests
✅ Weak acceptance criteria
✅ Not simulating real operating conditions
✅ Insufficient run data or sampling
✅ Delayed deviation documentation
✅ Poor traceability of qualification records
How can teams avoid these issues?
🔹 Use approved protocols and checklists
🔹 Define acceptance criteria clearly
🔹 Train staff before execution
🔹 Document deviations immediately
🔹 Review results carefully
🔹 Maintain traceable GMP records
Want to strengthen your IQ, OQ, and PQ execution skills?
👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course:
https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification | 3 065 |
| 17 | ⚙️ Common Pitfalls in IQ, OQ, and PQ
.
✅ Incomplete installation records
✅ Missing utility or component checks
✅ Poorly defined test parameters
✅ Untrained personnel running tests
✅ Weak acceptance criteria
✅ Not simulating real operating conditions
✅ Insufficient run data or sampling
✅ Delayed deviation documentation
✅ Poor traceability of qualification records
How can teams avoid these issues?
🔹 Use approved protocols and checklists
🔹 Define acceptance criteria clearly
🔹 Train staff before execution
🔹 Document deviations immediately
🔹 Review results carefully
🔹 Maintain traceable GMP records
Want to strengthen your IQ, OQ, and PQ execution skills?
👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course:
https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification | 1 |
| 18 | GLP vs GMP Presentation | 3 746 |
| 19 | British Pharmacopoeia Comparison with other USP , EU | 4 356 |
| 20 | Top Pharma Regulatory Bodies
50 MOST ASKED QUESTIONS & ANSWERS | 4 199 |
Уже доступно! Исследование Telegram 2025 — ключевые инсайты года 
